Investment in Biosynthetic Technologies

Biosynthetic Technologies has raised $7.5 million in a series A-1 funding led by HG Ventures, the corporate venture arm of The Heritage Group.

The money is being used to fund the company’s acquisition of Innoleo, a distributor of oleo derivatives, and to scale up its operations.

Biosynthetic manufactures a new class of biobased synthetic compounds called Estolides, which are made from organic fatty acids found in various bio-derived oils. They have applications in various industries, including personal care.

Latest Issues

Connex-C Asia 2025

Lee Kong Chian School of Medicine - Ong Tiong Tat and Irene Tan Liang Kheng Auditorium 11 Mandalay Road, Level 4, Singapore 308232
31 July - 1 August 2025

IFSCC Congress 2025

Palais des Festivals, Cannes
15th - 18th September 2025